4//SEC Filing
Markels John 4
Accession 0001209191-22-034538
CIK 0001001233other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:41 PM ET
Size
5.3 KB
Accession
0001209191-22-034538
Insider Transaction Report
Form 4
Markels John
Director
Transactions
- Purchase
Common Stock
2022-06-03$3.69/sh+6,784$25,029→ 32,484 total
Footnotes (1)
- [F1]Includes (a) 1,667 shares subject to the Reporting Person's February 11, 2020 restricted stock unit ("RSU") grant that will vest in one final annual installment on February 11, 2023 and (b) 12,500 shares subject to the Reporting Person's February 25, 2022 RSU grant that will fully vest in one installment on February 25, 2023. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001803424
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:41 PM ET
- Size
- 5.3 KB